Evidence map›Paper›PMID 42631054›Full record

ArticleiScience2026

A text mining and ontology-based approach using phenotypes to obtain relevant literature for rare diseases.

Jesús Pérez-García, Federico García-Criado, Florencio Pazos, Mónica Chagoyen, Elena Rojano, Pedro Seoane, Juan A G Ranea

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jesús Pérez-GarcíaDepartment of Molecular Biology and Biochemistry, University of Malaga, 29010 Malaga, Spain.
Federico García-CriadoDepartment of Molecular Biology and Biochemistry, University of Malaga, 29010 Malaga, Spain.
Florencio PazosComputational Systems Biology, National Center for Biotechnology (CNB-CSIC), 28049 Madrid, Spain.
Mónica ChagoyenComputational Systems Biology, National Center for Biotechnology (CNB-CSIC), 28049 Madrid, Spain.
Elena RojanoDepartment of Molecular Biology and Biochemistry, University of Malaga, 29010 Malaga, Spain.
Pedro SeoaneDepartment of Molecular Biology and Biochemistry, University of Malaga, 29010 Malaga, Spain.
Juan A G RaneaDepartment of Molecular Biology and Biochemistry, University of Malaga, 29010 Malaga, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing rare diseases remains a major challenge due to limited clinical knowledge and the frequent absence of diagnostic criteria. We present a digital framework that leverages large language models and biomedical text embeddings to bridge this gap. By mapping Human Phenotype Ontology terms to a shared vector space with millions of PubMed abstracts and full-text articles, our method enables phenotype-driven semantic search and ranks literature relevant to patient symptoms, even without explicit disease mentions. Validated on OMIM-derived benchmarks and applied to RASopathies, including NF1, Noonan, and Costello syndromes, our approach retrieved expected findings, supporting differential diagnosis and research. The framework is implemented in an open-source Python package, py-semtools, and it can be integrated into clinical decision support systems or adapted to other ontologies and corpora. This work demonstrates how AI-driven informatics can enhance rare disease diagnosis and exemplifies the role of digital tools in transforming precision medicine and healthcare delivery.

Indexed as

human phenotype ontologylanguage modelsphenotypic profilingrare diseasessemantic similaritytext mining

Identifiers

PMID42631054
PMCPMC13495350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.